The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Nasal decolonization of Staphylococcus aureus with mupirocin: strengths, weaknesses and future prospects
Open accessAbstract
Staphylococcus aureus in the nose is a risk factor for endogenous staphylococcal infection.UK guidelines recommend the use of mupirocin for nasal decolonization in certain groups of patients colonized with methicillin-resistant S. aureus (MRSA).Mupirocin is effective at removing S. aureus from the nose over a few weeks, but relapses are common within several months.There are only a few prospective randomized clinical trials that have been completed with sufficient patients, but those that have been reported suggest that clearance of S. aureus from the nose is beneficial in some patient groups for the reduction in the incidence of nosocomial infections.There is no convincing evidence that mupirocin treatment reduces the incidence of surgical site infection.New antibiotics are needed to decolonize the nose because bacterial resistance to mupirocin is rising, and so it will become less effective.Furthermore, a more bactericidal antibiotic than mupirocin is needed, on the grounds that it might reduce the relapse rate, and so clear the patient of MRSA for a longer period of time than mupirocin.Keywords: antimicrobials, infection control, MRSA, nosocomial, surgical Nasal decolonization of methicillin-susceptible Staphylococcus aureus (MSSA) and methicillin-resistant S. aureus (MRSA) is currently used in some countries for specific patient groups.For example, in the UK it is recommended 1 that carriers of MRSA, who are receiving prophylaxis for an operation, should undergo nasal decolonization with mupirocin.Mupirocin is effective at removing S. aureus from the nose over a few weeks, but nasal relapses are common within several months.2 There are few prospective randomized clinical trials (RCTs) with sufficient patients to achieve statistical significance that have been completed in this field.3 Taken together, these trials suggest that clearance of S. aureus from the nose is beneficial in some patient groups.4 This paper describes the risks, benefits and importance of patient selection in the use of mupirocin to decolonize the anterior nares.S. aureus strains MSSA lives on the skin of humans as a commensal.In developed countries 30% 5 -7 of the general adult population are colonized, although the data range from as low as 15% 8 up to 100%, in specific populations, such as those with MSSA skin infections.9 Nasal colonization (stable colonization is defined as S. aureus in the nose detected from nasal swabs taken several days apart) with strains such as MRSA is much lower, at 1% of the total population, 10 and is more frequent in certain subgroups of patients such as frequently hospitalized people, those of advancing age, patients on dialysis, AIDS patients and diabetics.1,11 Colonization with MRSA has been shown to increase the risk of infection with MRSA both immediately after colonization 12 and in long-term carriers, of whom 23% develop MRSA infections in the year following the identification of their carriage status.13 Patients who have had contact with healthcare facilities such as hospitals may be colonized in the nose with healthcare-associated (HA) MRSA.A different set of MRSA strains affects patients who have not had recent contact with healthcare units, and these strains are called community-associated (CA) MRSA.HA-MRSA usually causes diseases such as bacteraemia and infective endocarditis that tend to be more multiresistant.In contrast ... ... .. ..
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The role of nasal carriage in Staphylococcus aureus infections
Wertheim, H. F., Melles, D. C., Vos, M. C., van Leeuwen, W., van Belkum, A., Verbrugh, H. A., & Nouwen, J. L. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70295-4 · Cited by 2,685
Nasal Carriage as a Source of Staphylococcus aureus Bacteremia
von Eiff, C., Becker, K., Machka, K., Stammer, H., & Peters, G. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101043440102 · Cited by 1,984
Cited by
Hurdle, J. G., O'Neill, A. J., Chopra, I., & Lee, R. E. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2474 · Cited by 871
Multidrug-Resistant Bacteria in the Community
van Duin, D., & Paterson, D. L. (2016) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2016.02.004 · Cited by 584
Current and Emerging Topical Antibacterials and Antiseptics: Agents, Action, and Resistance Patterns
Williamson, D. A., Carter, G. P., & Howden, B. P. (2017) · Clinical Microbiology Reviews · doi:10.1128/cmr.00112-16 · Cited by 374
Staphylococcus colonization of the skin and antimicrobial peptides
Otto, M. (2010) · Expert Review of Dermatology · doi:10.1586/edm.10.6 · Cited by 262
Metadata
- Authors
- Coates, T., Bax, R., & Coates, A.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-05-18
- Volume
- 64
- Issue
- 1
- Pages
- 9-15
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2137352244
- Cited by
- 181
- References
- 2
- FWCI
- 11.10
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Nasal decolonization of Staphylococcus aureus with mupirocin: strengths, weaknesses and future prospects. https://app.cochat.ai/papers/10.1093/jac/dkp159
- The paper
- Coates, T., Bax, R., & Coates, A. (2009). Nasal decolonization of Staphylococcus aureus with mupirocin: strengths, weaknesses and future prospects. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkp159
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.